ResMed (ASX:RMD) share price on watch after solid Q2 update

The ResMed Inc (ASX:RMD) share price will be on watch today after the release of a solid second quarter update this morning…

| More on:
A young woman smiling and looking happy, indicating a positive share price movement on the ASX market

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price will be on watch on Friday following the release of its second quarter update this morning.

How is ResMed performing?

ResMed continued its strong form during the second quarter and delivered further revenue and profit growth.

According to the release, for the three months ended 31 December, ResMed reported a 9% increase in revenue to US$800 million.

Also heading in the right direction was the company's gross margin. It reported a non-GAAP gross margin of 59.9%, up 20 basis points on the prior corresponding period.

This underpinned a 17% increase in net profit to US$206.4 million and earnings per share to US$1.41.

What were the drivers of its growth?

ResMed's CEO, Mick Farrell, revealed that the company's growth was driven by a solid performance across the business.

He commented: "Our second-quarter results reflect continued solid performance and positive trends across our business resulting in top-line growth as well as double-digit improvement in operating income and earnings per share."

"In our core markets of sleep apnea, COPD, and asthma, we are seeing continued sequential improvement in new patient volume and ongoing adoption of our mask and accessories resupply programs. Our global teams have managed SG&A investments judiciously as we navigate through the global pandemic."

Mr Farrel revealed that its digital health business has been performing strongly thanks to the growing importance of out-of-hospital care.

He explained: "We have seen great adoption of digital health and an increase in the importance of out-of-hospital healthcare these last 12 months, and that will only expand throughout 2021 as vaccines become more widely available, and our communities open up worldwide."

"We have continued to invest in focused R&D programs in digital health and core medtech innovation, to help accelerate our ResMed growth strategy: improving 250 million lives in out-of-hospital healthcare in 2025," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A woman wearing a flowing red dress, poses dramatically on a beach with the sea in the background.
Share Market News

Here are the top 10 ASX 200 shares today

It was a disastrous session for ASX investors this Thursday...

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
52-Week Highs

3 ASX 300 shares smashing new highs while the market dives

These three shares are running hot amid a market meltdown.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Champion Iron, EBR Systems, Mesoblast, and Patriot Battery Metals shares are surging today

These shares are avoiding the market selloff on Thursday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why AGL, CBA, Deep Yellow, and Megaport shares are sinking today

These shares are falling more than most today. What's going on?

Read more »

A wide-eyed man peers out from a small gap in his black zipped jumper conveying fear over the weak Zip share price
BNPL shares

Why did the Zip share price just crash 9%?

Investors seem to be singling Zip out for punishment today...

Read more »

Unsure man analysing data on laptop.
Share Market News

Why is the ASX 200 down by so much today?

ASX 200 investors are favouring their sell buttons today. But why?

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Guess which ASX 50 share is a top buy for 2025

Bell Potter has just slapped a buy rating on this stock. Let's see why.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Goldman Sachs just put a buy rating on this ASX 200 share

The broker has good things to say about this 'high-quality' company.

Read more »